Bournemouth University researchers are seeking participants for a survey to explore peoples’ experience with medicine for MS, and the attitudes of prescribing clinicians. The survey is being conducted in Australia, Canada, UK, U.S., Spain, France, and Germany.
 
There is evidence that the use of medicines in MS may be delayed or impaired because of fears about factors such as drug side effects and/or a lack of belief in their benefits. At the same time relatively little is published about how such problems can best be addressed and the priorities that people with MS have for future treatment improvements. The survey will explore what patients value most from their treatment and their key expectations for their treatment. The survey will provide insight in to the behavioral decisions that delay patients from taking their medication.
 
It will take approximatively 15 minutes. All answers are confidential and names and email address are not linked with any responses. The study organizers believe your information will provide key insights that will contribute to improving care standards and health outcomes, and these insights will build upon the ongoing academic research that is being carried out at Bournemouth University. The results will be reported in a publication around the research project and will inform the transformation of MS treatment options to be more in line with patients’ unique needs and preferences. They will publish the findings at www.sos-adherence.co.uk
 
At the end of the questionnaire, participants are offered a $20 Amazon gift certificate.
 
To take part in the study visit sos-adherence.co.uk/research/tap-ms/
 
This research is being conducted by Spoonful of Sugar (a behaviour change consultancy that specializes in helping patients make the most of their medicines) in collaboration with Bournemouth University, England, UK.
 
For more information, contact info@sos-adherence.co.uk and add ‘TaP–MS’ to the subject heading.